Mechanisms of Type 2 Inflammation Mid-career Award
This award funds mid-career researchers advancing scientific understanding of Type 2 inflammation mechanisms in dermatological diseases like atopic dermatitis and bullous pemphigoid.
Funder: Dermatology Foundation
Due Dates: December 1, 2025 | December 1, 2026 | January 1, 2027
Funding Amounts: $100,000 per year for up to 3 years (total up to $300,000 per awardee)
Summary: Supports mid-career investigators advancing research on dermatological issues related to mechanisms of Type 2 inflammation.
Description
The Mechanisms of Type 2 Inflammation Mid-Career Award, supported by the Dermatology Foundation and Sanofi-Regeneron, is designed to propel the research of outstanding mid-career investigators in dermatology. The award focuses on advancing innovative basic, clinical, or translational research that deepens understanding of mechanisms underlying Type 2 inflammation in skin disorders. Projects are expected to yield new insights into dermatological conditions such as atopic dermatitis, prurigo nodularis, bullous pemphigoid, and other Type 2 inflammation-related diseases. The program aims to support researchers at a pivotal career stage, helping them establish independent research trajectories and compete for major external funding.
